443 related articles for article (PubMed ID: 19196661)
21. Sialic Acid-Siglec-E Interactions Regulate the Response of Neonatal Macrophages to Group B Streptococcus.
Lund SJ; Del Rosario PGB; Honda A; Caoili KJ; Hoeksema MA; Nizet V; Patras KA; Prince LS
Immunohorizons; 2024 May; 8(5):384-396. PubMed ID: 38809232
[TBL] [Abstract][Full Text] [Related]
22. Leishmania donovani Utilize Sialic Acids for Binding and Phagocytosis in the Macrophages through Selective Utilization of Siglecs and Impair the Innate Immune Arm.
Roy S; Mandal C
PLoS Negl Trop Dis; 2016 Aug; 10(8):e0004904. PubMed ID: 27494323
[TBL] [Abstract][Full Text] [Related]
23. Viewing Siglecs through the lens of tumor immunology.
Fraschilla I; Pillai S
Immunol Rev; 2017 Mar; 276(1):178-191. PubMed ID: 28258691
[TBL] [Abstract][Full Text] [Related]
24. Siglecs at the Host-Pathogen Interface.
Chang YC; Nizet V
Adv Exp Med Biol; 2020; 1204():197-214. PubMed ID: 32152948
[TBL] [Abstract][Full Text] [Related]
25. Tamm-Horsfall glycoprotein engages human Siglec-9 to modulate neutrophil activation in the urinary tract.
Patras KA; Coady A; Olson J; Ali SR; RamachandraRao SP; Kumar S; Varki A; Nizet V
Immunol Cell Biol; 2017 Nov; 95(10):960-965. PubMed ID: 28829050
[TBL] [Abstract][Full Text] [Related]
26. Structural implications of Siglec-5-mediated sialoglycan recognition.
Zhuravleva MA; Trandem K; Sun PD
J Mol Biol; 2008 Jan; 375(2):437-47. PubMed ID: 18022638
[TBL] [Abstract][Full Text] [Related]
27. Paired Siglec receptors generate opposite inflammatory responses to a human-specific pathogen.
Schwarz F; Landig CS; Siddiqui S; Secundino I; Olson J; Varki N; Nizet V; Varki A
EMBO J; 2017 Mar; 36(6):751-760. PubMed ID: 28100677
[TBL] [Abstract][Full Text] [Related]
28. Decreased erythrocyte binding of Siglec-9 increases neutrophil activation in sickle cell disease.
Kiser ZM; Lizcano A; Nguyen J; Becker GL; Belcher JD; Varki AP; Vercellotti GM
Blood Cells Mol Dis; 2020 Mar; 81():102399. PubMed ID: 31901888
[TBL] [Abstract][Full Text] [Related]
29. Human Siglec-5 inhibitory receptor and immunoglobulin A (IgA) have separate binding sites in streptococcal beta protein.
Nordström T; Movert E; Olin AI; Ali SR; Nizet V; Varki A; Areschoug T
J Biol Chem; 2011 Sep; 286(39):33981-91. PubMed ID: 21795693
[TBL] [Abstract][Full Text] [Related]
30. Different patterns of Siglec-9-mediated neutrophil death responses in septic shock.
von Gunten S; Jakob SM; Geering B; Takala J; Simon HU
Shock; 2009 Oct; 32(4):386-92. PubMed ID: 19295491
[TBL] [Abstract][Full Text] [Related]
31. Cloning and characterization of Siglec-10, a novel sialic acid binding member of the Ig superfamily, from human dendritic cells.
Li N; Zhang W; Wan T; Zhang J; Chen T; Yu Y; Wang J; Cao X
J Biol Chem; 2001 Jul; 276(30):28106-12. PubMed ID: 11358961
[TBL] [Abstract][Full Text] [Related]
32. Siglec-5 is an inhibitory immune checkpoint molecule for human T cells.
Vuchkovska A; Glanville DG; Scurti GM; Nishimura MI; White P; Ulijasz AT; Iwashima M
Immunology; 2022 Jun; 166(2):238-248. PubMed ID: 35290663
[TBL] [Abstract][Full Text] [Related]
33. Rapid evolution of binding specificities and expression patterns of inhibitory CD33-related Siglecs in primates.
Padler-Karavani V; Hurtado-Ziola N; Chang YC; Sonnenburg JL; Ronaghy A; Yu H; Verhagen A; Nizet V; Chen X; Varki N; Varki A; Angata T
FASEB J; 2014 Mar; 28(3):1280-93. PubMed ID: 24308974
[TBL] [Abstract][Full Text] [Related]
34. NeuA sialic acid O-acetylesterase activity modulates O-acetylation of capsular polysaccharide in group B Streptococcus.
Lewis AL; Cao H; Patel SK; Diaz S; Ryan W; Carlin AF; Thon V; Lewis WG; Varki A; Chen X; Nizet V
J Biol Chem; 2007 Sep; 282(38):27562-71. PubMed ID: 17646166
[TBL] [Abstract][Full Text] [Related]
35. Engagement of myelomonocytic Siglecs by tumor-associated ligands modulates the innate immune response to cancer.
Läubli H; Pearce OM; Schwarz F; Siddiqui SS; Deng L; Stanczak MA; Deng L; Verhagen A; Secrest P; Lusk C; Schwartz AG; Varki NM; Bui JD; Varki A
Proc Natl Acad Sci U S A; 2014 Sep; 111(39):14211-6. PubMed ID: 25225409
[TBL] [Abstract][Full Text] [Related]
36. Deacetylated sialic acids modulates immune mediated cytotoxicity via the sialic acid-Siglec pathway.
Grabenstein S; Barnard KN; Anim M; Armoo A; Weichert WS; Bertozzi CR; Parrish CR; Willand-Charnley R
Glycobiology; 2021 Nov; 31(10):1279-1294. PubMed ID: 34192335
[TBL] [Abstract][Full Text] [Related]
37. Siglec-8 and Siglec-9 binding specificities and endogenous airway ligand distributions and properties.
Yu H; Gonzalez-Gil A; Wei Y; Fernandes SM; Porell RN; Vajn K; Paulson JC; Nycholat CM; Schnaar RL
Glycobiology; 2017 Jul; 27(7):657-668. PubMed ID: 28369504
[TBL] [Abstract][Full Text] [Related]
38. Siglec-9, a novel sialic acid binding member of the immunoglobulin superfamily expressed broadly on human blood leukocytes.
Zhang JQ; Nicoll G; Jones C; Crocker PR
J Biol Chem; 2000 Jul; 275(29):22121-6. PubMed ID: 10801862
[TBL] [Abstract][Full Text] [Related]
39. Sialic acids acquired by Pseudomonas aeruginosa are involved in reduced complement deposition and siglec mediated host-cell recognition.
Khatua B; Ghoshal A; Bhattacharya K; Mandal C; Saha B; Crocker PR; Mandal C
FEBS Lett; 2010 Feb; 584(3):555-61. PubMed ID: 19945458
[TBL] [Abstract][Full Text] [Related]
40. Fisher scientific award lecture - the capsular polysaccharides of Group B Streptococcus and Streptococcus suis differently modulate bacterial interactions with dendritic cells.
Segura M
Can J Microbiol; 2012 Mar; 58(3):249-60. PubMed ID: 22356626
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
